Cargando…

The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review

Regorafenib, a multi-kinase inhibitor, has been widely used to treat patients with gastrointestinal stromal tumors (GIST) who failed the initial treatment with imatinib and sunitinib. This systematic review aims to demonstrate the efficacy and safety of regorafenib for patients with metastatic and/o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khachatryan, Vahe, Muazzam, Asmaa, Hamal, Chandani, Velugoti, Lakshmi Sai Deepak Reddy, Tabowei, Godfrey, Gaddipati, Greeshma N, Mukhtar, Maria, Alzubaidee, Mohammed J, Dwarampudi, Raga Sruthi, Mathew, Sheena, Bichenapally, Sumahitha, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526434/
https://www.ncbi.nlm.nih.gov/pubmed/36199644
http://dx.doi.org/10.7759/cureus.28665
_version_ 1784800875685871616
author Khachatryan, Vahe
Muazzam, Asmaa
Hamal, Chandani
Velugoti, Lakshmi Sai Deepak Reddy
Tabowei, Godfrey
Gaddipati, Greeshma N
Mukhtar, Maria
Alzubaidee, Mohammed J
Dwarampudi, Raga Sruthi
Mathew, Sheena
Bichenapally, Sumahitha
Mohammed, Lubna
author_facet Khachatryan, Vahe
Muazzam, Asmaa
Hamal, Chandani
Velugoti, Lakshmi Sai Deepak Reddy
Tabowei, Godfrey
Gaddipati, Greeshma N
Mukhtar, Maria
Alzubaidee, Mohammed J
Dwarampudi, Raga Sruthi
Mathew, Sheena
Bichenapally, Sumahitha
Mohammed, Lubna
author_sort Khachatryan, Vahe
collection PubMed
description Regorafenib, a multi-kinase inhibitor, has been widely used to treat patients with gastrointestinal stromal tumors (GIST) who failed the initial treatment with imatinib and sunitinib. This systematic review aims to demonstrate the efficacy and safety of regorafenib for patients with metastatic and/or unresectable GIST. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to perform this systematic review. We searched PubMed, Science Direct, and Cochrane databases to identify relevant articles based on predefined selection criteria. The implication of the search strategy results in 776 records from all databases. We excluded conference abstracts, discussion articles, case reports, case series, systematic reviews, and other observational non-intervention studies from the study, along with the articles published in languages other than English. After the screening and quality assessment, 10 studies were selected for final review - two randomized controlled trials and eight non-randomized prospective and retrospective review articles of intervention. Regorafenib improved the survival rates of patients after the failure of imatinib and sunitinib treatment, with an acceptable safety profile. Close monitoring of the patients may be needed to detect and manage the grade 4 or higher adverse events.
format Online
Article
Text
id pubmed-9526434
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-95264342022-10-04 The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review Khachatryan, Vahe Muazzam, Asmaa Hamal, Chandani Velugoti, Lakshmi Sai Deepak Reddy Tabowei, Godfrey Gaddipati, Greeshma N Mukhtar, Maria Alzubaidee, Mohammed J Dwarampudi, Raga Sruthi Mathew, Sheena Bichenapally, Sumahitha Mohammed, Lubna Cureus Internal Medicine Regorafenib, a multi-kinase inhibitor, has been widely used to treat patients with gastrointestinal stromal tumors (GIST) who failed the initial treatment with imatinib and sunitinib. This systematic review aims to demonstrate the efficacy and safety of regorafenib for patients with metastatic and/or unresectable GIST. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to perform this systematic review. We searched PubMed, Science Direct, and Cochrane databases to identify relevant articles based on predefined selection criteria. The implication of the search strategy results in 776 records from all databases. We excluded conference abstracts, discussion articles, case reports, case series, systematic reviews, and other observational non-intervention studies from the study, along with the articles published in languages other than English. After the screening and quality assessment, 10 studies were selected for final review - two randomized controlled trials and eight non-randomized prospective and retrospective review articles of intervention. Regorafenib improved the survival rates of patients after the failure of imatinib and sunitinib treatment, with an acceptable safety profile. Close monitoring of the patients may be needed to detect and manage the grade 4 or higher adverse events. Cureus 2022-09-01 /pmc/articles/PMC9526434/ /pubmed/36199644 http://dx.doi.org/10.7759/cureus.28665 Text en Copyright © 2022, Khachatryan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Khachatryan, Vahe
Muazzam, Asmaa
Hamal, Chandani
Velugoti, Lakshmi Sai Deepak Reddy
Tabowei, Godfrey
Gaddipati, Greeshma N
Mukhtar, Maria
Alzubaidee, Mohammed J
Dwarampudi, Raga Sruthi
Mathew, Sheena
Bichenapally, Sumahitha
Mohammed, Lubna
The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title_full The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title_fullStr The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title_full_unstemmed The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title_short The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review
title_sort role of regorafenib in the management of advanced gastrointestinal stromal tumors: a systematic review
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526434/
https://www.ncbi.nlm.nih.gov/pubmed/36199644
http://dx.doi.org/10.7759/cureus.28665
work_keys_str_mv AT khachatryanvahe theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT muazzamasmaa theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT hamalchandani theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT velugotilakshmisaideepakreddy theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT taboweigodfrey theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT gaddipatigreeshman theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mukhtarmaria theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT alzubaideemohammedj theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT dwarampudiragasruthi theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mathewsheena theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT bichenapallysumahitha theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mohammedlubna theroleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT khachatryanvahe roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT muazzamasmaa roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT hamalchandani roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT velugotilakshmisaideepakreddy roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT taboweigodfrey roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT gaddipatigreeshman roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mukhtarmaria roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT alzubaideemohammedj roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT dwarampudiragasruthi roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mathewsheena roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT bichenapallysumahitha roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview
AT mohammedlubna roleofregorafenibinthemanagementofadvancedgastrointestinalstromaltumorsasystematicreview